Phileo and PhageLab Partner for Poultry Health

The companies are joining forces to develop bacteriophage-based solutions to combat pathogens in the poultry industry.

Updated on Oct. 30, 2026 in Life Sciences

Close-up of glass biological vials in a laboratory incubator, representing precision-engineered poultry health solutions.
Phileo by Lesaffre and PhageLab have formed a strategic partnership to develop bacteriophage-based solutions to improve pathogen management in the global poultry industry. AI Illustration. Upload story photo >

Live Poll

Would you feel comfortable eating poultry treated with bacteriophage-based products to combat harmful pathogens?

Phileo by Lesaffre and PhageLab have established a strategic partnership to create bacteriophage products designed to target harmful poultry bacteria. The collaboration will prioritize the Latin American market before expanding to a global scale.

Why it matters

The initiative aims to address antimicrobial resistance and improve food safety by utilizing targeted viral solutions that eliminate specific bacteria. This approach seeks to provide a more precise alternative to traditional methods for managing health in poultry production.

PhageLab brings 16 years of research and development experience in bacteriophage technology to the partnership. This collaboration integrates Phileo's established feed additive platforms with specialized data-driven bacterial diagnostics.

The players

Phileo by Lesaffre

A global company that focuses on the production of microbial solutions for animal nutrition and health.

PhageLab

A biotechnology firm that specializes in the research and development of bacteriophage technology for animal health applications.

The details

By combining Phileo's global market reach with PhageLab's expertise in developing targeted bacteriophage solutions, the companies plan to tackle regional bacterial challenges in livestock. These viruses are engineered to identify and eliminate specific pathogens, enhancing overall animal health and safety standards.

Timeline

  1. PhageLab was founded in Chile in 2010.

  2. The companies officially announced their partnership on October 30, 2026.

The Big Picture

The partnership aligns with the WHO global action plan on antimicrobial resistance by offering non-antibiotic alternatives to manage bacterial threats. This move represents a shift in agricultural practices toward precision biological interventions rather than broad-spectrum treatments.

This development could eventually lead to safer poultry products for consumers by reducing the use of traditional antibiotics in livestock production. As the products reach global markets, shoppers may find more food options produced with an emphasis on antimicrobial-free health management.

The takeaway

Using bacteriophages provides a highly specific method to control pathogens without affecting beneficial bacteria or contributing to resistance. Producers looking to improve animal health should monitor how these data-driven diagnostics perform in regional field testing.

Further reading

Learn more about the latest innovations in Life Sciences.

Source note: This article includes information reported by Feedstuffs.

Live Poll

Would you feel comfortable eating poultry treated with bacteriophage-based products to combat harmful pathogens?